Mannkind and United Therapeutics are creating an inhaled formulation of ralinepag, an experimental oral PAH treatment.

Treatment with treprostinil led to significant and sustained improvements in children with PH associated with lung disease, ...

The analysis revealed dozens of genes with abnormal expression in cells from people with idiopathic PAH, and the researchers ...

“This study provides comprehensive preclinical evidence that the novel PDE5 inhibitor CPD1 is a potent therapeutic candidate ...

World Pulmonary Hypertension Day 2026 highlights hope through clinical trials for the global disease community.

Corvista Health and Mayo Clinic will study whether Corvista-PH can improve pulmonary hypertension diagnosis and referrals.

Irregular heart rhythms in people with pulmonary arterial hypertension are linked to a greater risk of poor outcomes, a U.S.

Elevated pulmonary vascular resistance (PVR), a measure of how difficult it is for blood to move from the heart to the lungs, was associated with a higher risk of poor outcomes in people with ...

The first participant has been enrolled in a two-part Phase 3 clinical trial testing IKT-001, Inhibikase Therapeutics’ experimental formulation of imatinib, in people with pulmonary arterial ...

Brittany Taylor shares how pulmonary hypertension (PH) reshaped her social life, and how rest, support, and pacing can help make daily life more manageable. Read Taylor’s column Recharged and Rewired.

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google A history of smoking was associated with worse survival outcomes ...